Patents by Inventor Niall Anderson

Niall Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ER DEGRADERS AND USES THEREOF
    Publication number: 20250177539
    Abstract: This specification relates to compounds according to Formula (I), which are of degraders of ER, to pharmaceutical compositions containing them, and to their use in therapy for the treatment of ER-sensitive and/or ER-directed diseases and disorders.
    Type: Application
    Filed: November 26, 2024
    Publication date: June 5, 2025
    Inventors: Niall ANDERSON, Marc André DÄMGEN, Laura EVANS, Charlene FALLAN, Frederick GOLDBERG, Thomas George Christopher HAYHOW, Johannes Wilhelmus Maria NISSINK, Martin John PACKER, James SCOTT, Oliver STEWARD
  • CATHEPSIN C INHIBITORS
    Publication number: 20120142668
    Abstract: Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 7, 2012
    Inventors: Niall Anderson, Ann M. Bullion, Neysa Nevins, Michael R. Palovich, Steven L. Sollis, Michael D. Wall, Jakob Busch-Petersen, Brian Evans, Huijie Li